Skip to main content
Premium Trial:

Request an Annual Quote

Iffmedic Marketing Multiplicom MDx Kits in Central Europe

NEW YORK (GenomeWeb News) – Iffmedic will market and sell Multiplicom's molecular diagnostic kits in Central Europe under a deal announced by the companies today.

Under the terms of the deal, the companies will co-promote Multiplicom's products, close sales agreements, and provide support to customers in Germany, Austria, and Eastern Europe. Multiplicom had already been selling its products in Germany.

Financial terms were of the deal not disclosed.

Based in Germany, Iffmedic sells in vitro diagnostic products in Central Europe and has more than a decade of experience in positioning molecular companion diagnostics, it said.

Multiplicom, spun out of the University of Antwerp and life sciences research institute VIB in 2011, is based in Belgium and develops, manufactures, and commercializes genetic tests based on molecular diagnostic technologies. In April 2011, it announced it had raised $3 million in financing.

The Scan

Wolf Howl Responses Offer Look at Vocal Behavior-Related Selection in Dogs

In dozens of domestic dogs listening to wolf vocalizations, researchers in Communication Biology see responses varying with age, sex, reproductive status, and a breed's evolutionary distance from wolves.

Facial Imaging-Based Genetic Diagnoses Appears to Get Boost With Three-Dimensional Approach

With data for more than 1,900 individuals affected by a range of genetic conditions, researchers compared facial phenotype-based diagnoses informed by 2D or 3D images in the European Journal of Human Genetics.

Survey Suggests Multigene Cancer Panel VUS Reporting May Vary Across Genetic Counselors

Investigators surveyed dozens of genetic counselors working in clinical or laboratory settings, uncovering attitudes around VUS reporting after multigene cancer panel testing in the Journal of Genetic Counseling.

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.